Posters Overview
The development of oral peptide therapeutics has gained significant attention in the pharmaceutical industry. However, one of the key challenges limiting peptide oral bioavailability is the poor permeability. To overcome this challenge, permeation enhancers (PEs) have emerged as a critical strategy in enhancing peptide delivery. Rodents have been commonly used for screening PEs for peptide therapeutics. To minimize animal testing and better align with FDA’s 3Rs (Replacement, Reduction, Refinement) principles, we developed a pre-screening strategy utilizing Caco-2 cells.

Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.